Title : [Genetic polymorphism in human drug metabolism].

Pub. Date : 1993 Feb

PMID : 8454228






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Debrisoquine/sparteine and mephenytoin polymorphisms are now known to be derived from defects in the human liver of specific forms of microsomal CYP (P450 or previously termed cytochrome P-450), CYP2D6 and CYP2C9 (2C18), respectively. Debrisoquin cytochrome P450 family 2 subfamily C member 9 Homo sapiens
2 Debrisoquine/sparteine and mephenytoin polymorphisms are now known to be derived from defects in the human liver of specific forms of microsomal CYP (P450 or previously termed cytochrome P-450), CYP2D6 and CYP2C9 (2C18), respectively. Sparteine cytochrome P450 family 2 subfamily C member 9 Homo sapiens
3 Debrisoquine/sparteine and mephenytoin polymorphisms are now known to be derived from defects in the human liver of specific forms of microsomal CYP (P450 or previously termed cytochrome P-450), CYP2D6 and CYP2C9 (2C18), respectively. Mephenytoin cytochrome P450 family 2 subfamily C member 9 Homo sapiens